1. Home
  2. ACLX vs TNET Comparison

ACLX vs TNET Comparison

Compare ACLX & TNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACLX
  • TNET
  • Stock Information
  • Founded
  • ACLX 2015
  • TNET 1988
  • Country
  • ACLX United States
  • TNET United States
  • Employees
  • ACLX N/A
  • TNET N/A
  • Industry
  • ACLX Biotechnology: Pharmaceutical Preparations
  • TNET Business Services
  • Sector
  • ACLX Health Care
  • TNET Consumer Discretionary
  • Exchange
  • ACLX Nasdaq
  • TNET Nasdaq
  • Market Cap
  • ACLX 5.3B
  • TNET 4.5B
  • IPO Year
  • ACLX 2022
  • TNET 2014
  • Fundamental
  • Price
  • ACLX $66.48
  • TNET $90.40
  • Analyst Decision
  • ACLX Strong Buy
  • TNET Buy
  • Analyst Count
  • ACLX 14
  • TNET 4
  • Target Price
  • ACLX $107.67
  • TNET $117.00
  • AVG Volume (30 Days)
  • ACLX 695.1K
  • TNET 253.1K
  • Earning Date
  • ACLX 02-26-2025
  • TNET 02-13-2025
  • Dividend Yield
  • ACLX N/A
  • TNET 1.11%
  • EPS Growth
  • ACLX N/A
  • TNET N/A
  • EPS
  • ACLX N/A
  • TNET 5.19
  • Revenue
  • ACLX $155,818,000.00
  • TNET $4,972,000,000.00
  • Revenue This Year
  • ACLX $12.58
  • TNET $3.15
  • Revenue Next Year
  • ACLX N/A
  • TNET $5.04
  • P/E Ratio
  • ACLX N/A
  • TNET $17.43
  • Revenue Growth
  • ACLX 230.33
  • TNET 1.41
  • 52 Week Low
  • ACLX $47.88
  • TNET $74.32
  • 52 Week High
  • ACLX $107.37
  • TNET $134.67
  • Technical
  • Relative Strength Index (RSI)
  • ACLX 32.63
  • TNET 46.55
  • Support Level
  • ACLX $63.63
  • TNET $88.49
  • Resistance Level
  • ACLX $68.24
  • TNET $93.64
  • Average True Range (ATR)
  • ACLX 3.71
  • TNET 2.15
  • MACD
  • ACLX -0.69
  • TNET 0.21
  • Stochastic Oscillator
  • ACLX 16.43
  • TNET 37.09

About ACLX Arcellx Inc.

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.

About TNET TriNet Group Inc.

TriNet offers outsourced payroll and human capital management solutions for small and midsize businesses via a professional employer organization model. Under the PEO model, TriNet enters a co-employment arrangement and acts as the employer of record for administrative and regulatory purposes for clients' employees, known as worksite employees. Clients leverage the scale and expertise of TriNet to access competitive employee benefits, share employment risk liability, access compliance support, and outsource mission-critical day-to-day HR functions such as payroll and tax administration. Following the acquisition of Zenefits and Clarus R+D in 2022, TriNet derives the minority of its revenue from self-service HCM software and R&D tax credit services.

Share on Social Networks: